Posted on August 27, 2009 - by admin
Bio-Matrix Scientific Group Inc. (BMSN.OB) Secures Partnership to Address Canine Cancer; Ultimate Plans for Human Treatment
Bio-Matrix Scientific Group Inc., a biotech research and development company, recently made a joint announcement with its subsidiary Entest BioMedical Inc. (ENTB.OB), a testing center for various diseases, that they have reached a definitive agreement with Therinject LLC for the development of a immune-therapeutic cancer vaccine
Here is the original post:
Bio-Matrix Scientific Group Inc. (BMSN.OB) Secures Partnership to Address Canine Cancer; Ultimate Plans for Human Treatment
This entry was posted on Thursday, August 27th, 2009 at 09:12 and is filed under Property Markets. You can follow any responses to this entry through the RSS 2.0 feed.
You can leave a response, or trackback from your own site.
